| Ytd | -37.50% | |
| 1y | -40.65% |
| Open | 2.00 | Prev Close | 1.99 | Low | 1.95 | High | 2.04 | Mkt Cap | 42.75M |
| Vol | 70.94K | Avg Vol | 658.20K | EPS | -2.74 | P/E | N/A | Forward P/E | -161.67 |
| Beta | 0.68 | Short Ratio | 3.46 | Inst. Own | 47.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 08-11 | Earning | 08-06 | 50-d Avg | 2.07 | 200-d Avg | 2.52 | 1yr Est | 3.75 |
PetMed Express, Inc. ("PetMeds" or the "Company") (NASDAQ:PETS) today confirmed that
DELRAY BEACH, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds” or the “Compan
PetMed Express ($PETS) stock surges after SilverCape Investments proposes a $3/share cash buyout, re
The proposed purchase price represents a premium of approximately 70% to PetMed’s closing share pric
Unaccountable Board Led by Chair & Interim CEO Leslie C.G. Campbell Continues to Preside Over Stunni
In December 2025, the Company received two unsolicited, non-binding preliminary proposals from two s
Pet spending stayed resilient in 2025 despite inflation. See which pet care stocks Wall Street is wa
PetMed Express shares rose again after Cardone Ventures floated a nonbinding all-cash buyout proposa
Cardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon an
PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Compan
PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company
PetMed Express, Inc. (the "Company") dba PetMeds and parent company of PetCareRx (NASDAQ:PET
PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS) received on July 2, 2025, an expected notice
Preliminary Fourth Quarter and FY 2025 Results:For the fiscal fourth quarter ended March 31, 2025, n
The Reporting Persons have been an investor in the Issuer since February 2025 and hold the Common St
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and
PetMed Express (NASDAQ:PETS) reported quarterly losses of $(0.03) per share which missed the analyst
PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) ("PetMeds" or
PetMed Express (NASDAQ:PETS) reported quarterly earnings of $0.11 per share which beat the analyst c
Lake Street analyst Ryan Meyers downgrades PetMed Express (NASDAQ:PETS) from Buy to Hold and lowe
PetMed Express (NASDAQ:PETS) reported quarterly earnings of $0.18 per share which beat the analyst c
PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company&#
A new reports shows consumers spending more on pet care, including premium products and health care.
Cat-themed cryptocurrencies surged Thursday after controversial trader "Roaring Kitty" retur
GameStop Corp. (NYSE: GME) and several pet-related stocks experienced significant upward movement on
https://x.com/TheRoaringKitty/status/1806371920495186041
Lake Street analyst Ryan Meyers maintains PetMed Express (NASDAQ:PETS) with a Buy and lowers the